Tbh the new tadalafil‑peptide conjugate: hype vs real benefits?

Posted by hank_m in Research & News - 1 points, 0 comments.

I just skimmed a 2024 paper in the Journal of Controlled Release that finally put the Tadalafil‑Peptide Conjugate on the map, and i’m curious how the community feels about it, bc the idea of targeting PDE5 inhibition just to the penis with a CPP sounds like a game‑changer, but i’m also wary of the hype. Atoi of regular tadalafil. I’ve been using the daily low‑dose for a while, and the headache has definitely been a pain point; i’m tempted to try the conjugate if it’s available, but i’d love to hear if anyone’s got any early anecdotal data or even a lab trial they’re following.

Could this actually be the “weekend pill” with fewer side effects, or is it just a clever marketing angle? Tbh i’d love to know what you think.

Community discussion - research and educational context only. Not medical advice.